The story of cannabis reform in Brazil began with a little girl, Anny, whose parents fought the Brazilian government for the right to import RSHO\u2122 for their daughter. Anny suffered from an intractable form of epilepsy that proved resistant to traditional treatments.<\/p>\n
After just three days hearing the family\u2019s case, the Brazilian courts ruled it \u201cinhumane\u201d to keep our RSHO\u2122 from Anny. The approval of our products eventually led to\u00a0<\/span>cannabidiol<\/a>\u00a0<\/span>(CBD) being removed from Brazil\u2019s controlled substances list and the approval of RSHO\u2122\u2019s first indication for use \u2013 all forms of\u00a0<\/span>epilepsy<\/a>. HempMeds\u00ae Brasil was there from the start to help organize patients and in acting to assist in their navigation of the difficult approval process to start importing RSHO\u2122.<\/p>\n <\/strong><\/p>\n <\/strong><\/p>\n Brazil went on to approve RSHO\u2122 for a pair of neurological diseases,\u00a0Alzheimer\u2019s disease<\/a>\u00a0and\u00a0Parkinson\u2019s disease<\/a>. Treatment solutions for these types neurological diseases are desperately needed because of the difficulty in developing pharmaceuticals that can pass the blood-brain barrier, a specialized system of cells that allow nutrients into the brain while preventing harmful substances from passing through. In the case of most neurological medications, this prevents the therapeutic agents from doing their job. Cannabinoids like CBD, however, are able to pass through the blood-brain barrier and affect cannabinoid receptors in the brain.<\/p>\n<\/div>\n<\/div>\n Then, late in 2015, Brazil added\u00a0<\/span>chronic pain<\/a>\u00a0<\/span>to the list of approved indications for the use of RSHO\u2122. The U.S. National Institutes of Health defines chronic pain as pain lasting more than three months. A pervasive condition, chronic pain\u00a0<\/span>affects 1.5 billion people<\/a>\u00a0<\/span>worldwide. Although there are already a number of pain medications on the market, the use of painkillers like opioids to treat chronic pain increases the danger of abuse and addiction to these dangerous drugs. Adding chronic pain to the list of approved indications in Brazil is a positive step towards securing a higher quality of life for pain sufferers in the country while taking steps to reduce the effects of long-term use of prescription painkillers.<\/p>\n \u201cAs more Brazilians gain access to cannabidiol (CBD) hemp oil, and see efficacy with these indications that affect billions of people worldwide, the world can\u2019t help but take notice,\u201d says Dr. Titus. \u201cThis is an important step for the U.S. economy exporting cannabis; hemp is on its way to exploding onto the global market. These approvals are what the company has been and will continue to push for. The approval of HempMeds Brasil\u2019s\u2122 products take the conversation from \u2013 if cannabis can become a drug and regulated appropriately \u2013 to that it has been and is now working in the healthcare system.\u201d<\/p>\n Medical Marijuana, Inc. is looking towards additional indications to be approved in Brazil for RSHO\u2122 in the future. Adding to the list of conditions for which RSHO\u2122 is prescribed furthers the acceptance of cannabis as medicine and helps us fulfill our mission of \u201caccess for all\u201d.<\/p>\n<\/div>\n<\/div>\n [\/et_pb_text][et_pb_text _builder_version=”4.10.7″ _module_preset=”default” header_4_font_size=”24px” global_colors_info=”{}”][\/et_pb_text][et_pb_button button_url=”https:\/\/medicalmarijuanainc.com\/we-are-a-company-of-firsts\/” button_text=”Back To Full Timeline” _builder_version=”4.10.7″ _module_preset=”default” global_colors_info=”{}”][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" WE ARE A COMPANY OF FIRSTS\u00aeTHE FIRST TO DELIVER PRESCRIPTION CBD PRODUCTS TO EPILEPSY, ALZHEIMER\u2019S DISEASE, PARKINSON\u2019S DISEASE, CHRONIC PAIN, AND MIGRAINE SUFFERERSHempMeds\u00ae Brasil, a subsidiary of Medical Marijuana, Inc., became the first company to have a cannabis product,\u00a0Real Scientific Hemp Oil\u2122(RSHO\u2122), prescribed for a number of indications when it was exported to Brazil for […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-253","page","type-page","status-publish","hentry"],"yoast_head":"\nHEMPMEDS\u00ae BRASIL WAS THERE FROM THE START TO ORGANIZE PATIENTS AND ASSIST IN THE APPROVAL PROCESS TO IMPORT RSHO\u2122.<\/strong><\/h3>\n
AS MORE BRAZILIANS GAIN ACCESS TO CANNABIDIOL (CBD) HEMP OIL, AND SEE EFFICACY WITH THESE INDICATIONS THAT AFFECT BILLIONS OF PEOPLE WORLDWIDE, THE WORLD CAN\u2019T HELP BUT TAKE NOTICE<\/strong><\/h3>\n